Found: 17
Select item for more details and to access through your institution.
Asporin Expression Is Highly Regulated in Human Chondrocytes.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 7/8, p. 816, doi. 10.2119/molmed.2011.00052
- By:
- Publication type:
- Article
TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells.
- Published in:
- BMC Complementary & Alternative Medicine, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12906-015-0748-7
- By:
- Publication type:
- Article
Modulation of Skin Inflammatory Response by Active Components of Silymarin.
- Published in:
- Molecules, 2019, v. 24, n. 1, p. 123, doi. 10.3390/molecules24010123
- By:
- Publication type:
- Article
Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8152, doi. 10.1038/ncomms9152
- By:
- Publication type:
- Article
Use of Adult Stem Cells for Cartilage Tissue Engineering: Current Status and Future Developments.
- Published in:
- Stem Cells International, 2015, v. 2015, p. 1, doi. 10.1155/2015/438026
- By:
- Publication type:
- Article
Type II TGFβ receptor modulates chondrocyte phenotype.
- Published in:
- Age, 2013, v. 35, n. 4, p. 1105, doi. 10.1007/s11357-012-9433-7
- By:
- Publication type:
- Article
Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.
- Published in:
- Aging & Disease, 2014, v. 5, n. 6, p. 394, doi. 10.14366/AD.2014.0500394
- By:
- Publication type:
- Article
Antiproliferative effect of the histone demethylase inhibitor GSK‐J4 in chondrosarcomas.
- Published in:
- IUBMB Life, 2019, v. 71, n. 11, p. 1711, doi. 10.1002/iub.2110
- By:
- Publication type:
- Article
Hypoxia inducible factor 1 alpha down-regulates type i collagen through Sp3 transcription factor in human chondrocytes.
- Published in:
- IUBMB Life, 2016, v. 68, n. 9, p. 756, doi. 10.1002/iub.1539
- By:
- Publication type:
- Article
Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseases.
- Published in:
- Journal of Inflammation, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12950-015-0062-7
- By:
- Publication type:
- Article
The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
- Published in:
- Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2019, v. 53, n. 4, p. 731, doi. 10.33594/000000168
- By:
- Publication type:
- Article
Description of Joint Alterations Observed in a Family Carrying p.Asn453Ser COMP Variant: Clinical Phenotypes, In Silico Prediction of Functional Impact on COMP Protein and Stability, and Review of the Literature.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
EZH2 inhibition reduces cartilage loss and functional impairment related to osteoarthritis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76724-9
- By:
- Publication type:
- Article
Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 1, p. 1, doi. 10.1186/ar3247
- By:
- Publication type:
- Article
Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4648, doi. 10.3390/cancers13184648
- By:
- Publication type:
- Article
The benefit of combining curcumin, bromelain and harpagophytum to reduce inflammation in osteoarthritic synovial cells.
- Published in:
- BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03435-7
- By:
- Publication type:
- Article
Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas.
- Published in:
- 2017
- By:
- Publication type:
- journal article